MDMA Therapy

Novel Approaches to Treating Social Anxiety in Autistic Adults

Presentation and Catered Reception

• Culver City, CA • Doors open at 7:00 p.m., Presentation 7:15-9:00 p.m., Reception 9:00-11:00 p.m. November 13, 2014

Researchers are conducting a clinical study investigating the safety and effectiveness of MDMA-assisted therapy for the treatment of social anxiety in 12 MDMA-naïve adults on the autism spectrum. The goal of this study is to determine if MDMA-assisted therapy can safely and effectively enhance functional skills in autistic adults, an underserved group which tends to experience greater anxiety, depression, and victimization than typically developing adults.



The Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization that is working on novel approaches to some of the worlds most challenging mental health issues, is sponsoring this collaborative study between the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and Stanford University.

Join MAPS staff and other visionary thinkers for a presentation and reception with Greek food and warm hospitality.

Rick Doblin, Ph.D., MAPS Founder and Executive Director

Charles Grob, M.D., Clinical Investigator Alicia Danforth, Ph.D., Co-Investigator

$15 Presentation

$50 Catered Reception

A limited number of discounted presentation tickets are available for students, veterans, and active duty US military personnel.

Contact Tess at 831-429-6362 x111 or tess@maps.org for details.

Depending on availability, tickets may be purchased at the door.

Located at the Veterans Memorial Building: 4117 Overland Ave, Culver City, CA 90230